Oncopro EGFR Rapid Test: Advanced EGFR Mutation Detection for Lung Cancer
Understanding the Oncopro EGFR Rapid Test
The Oncopro EGFR Rapid Test represents a breakthrough in personalized cancer medicine, specifically designed for patients with non-small cell lung cancer (NSCLC). This sophisticated molecular diagnostic test utilizes Real-Time PCR technology to detect mutations in the Epidermal Growth Factor Receptor (EGFR) gene, which plays a critical role in cancer cell growth and proliferation.
EGFR mutations are present in approximately 10-15% of lung cancer patients in the United States, with higher prevalence among non-smokers, women, and individuals of Asian descent. Identifying these mutations is essential because they predict response to targeted therapies known as EGFR tyrosine kinase inhibitors (TKIs), which can dramatically improve treatment outcomes compared to traditional chemotherapy.
What the Test Measures and Detects
The Oncopro EGFR Rapid Test specifically identifies:
- Common EGFR mutations including exon 19 deletions and exon 21 L858R point mutations
- Less common EGFR mutations that may still respond to targeted therapies
- T790M resistance mutations that can develop during treatment
- Other clinically relevant EGFR alterations that impact treatment decisions
This comprehensive analysis provides oncologists with the precise genetic information needed to select the most effective targeted therapy for each individual patient.
Who Should Consider This Test
Primary Candidates Include:
- Patients newly diagnosed with advanced non-small cell lung cancer
- Individuals with metastatic lung adenocarcinoma
- Patients who have never smoked or are light smokers
- Those of Asian ethnicity with lung cancer
- Patients considering first-line treatment options for advanced NSCLC
- Individuals whose previous treatments have stopped working
Symptoms That May Indicate Need for Testing:
- Persistent cough that doesn’t go away
- Chest pain that worsens with deep breathing
- Shortness of breath or wheezing
- Coughing up blood or rust-colored phlegm
- Unexplained weight loss and fatigue
- Recurrent respiratory infections
Benefits of Taking the Oncopro EGFR Rapid Test
Personalized Treatment Approach
By identifying specific EGFR mutations, this test enables oncologists to prescribe targeted therapies that are significantly more effective than traditional chemotherapy for mutation-positive patients. This personalized approach can lead to:
- Higher response rates to treatment
- Longer progression-free survival
- Improved quality of life with fewer side effects
- Reduced exposure to ineffective treatments
Rapid Results for Timely Decisions
With our accelerated testing protocol, samples received by 11 AM daily yield results the next working day. This rapid turnaround time ensures that treatment decisions can be made promptly, reducing patient anxiety and enabling faster initiation of appropriate therapy.
Comprehensive Genetic Profiling
The test provides a complete picture of EGFR mutation status, including both common and rare mutations that may impact treatment selection and prognosis.
Understanding Your Test Results
Positive Result (EGFR Mutation Detected)
A positive result indicates the presence of EGFR mutations that are likely to respond to targeted therapy. Your oncologist will discuss appropriate EGFR tyrosine kinase inhibitor options, which may include medications such as osimertinib, gefitinib, erlotinib, or afatinib.
Negative Result (No EGFR Mutation Detected)
A negative result means no targetable EGFR mutations were detected in the sample. Your treatment team will explore other therapeutic options, which may include immunotherapy, chemotherapy, or testing for other genetic alterations.
Inconclusive Result
In some cases, the test may be inconclusive due to insufficient tumor tissue or technical factors. Your healthcare provider will discuss whether repeat testing is necessary.
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Oncopro EGFR Rapid Test | $438 USD | $488 USD |
Sample Requirements and Processing
The test requires submission of a formalin-fixed paraffin-embedded (FFPE) tissue block containing at least 10% tumor tissue. Samples should be shipped at room temperature to ensure sample integrity. Our specialized molecular diagnostics laboratory maintains strict quality control measures to ensure accurate and reliable results.
Nationwide Availability
We have testing facilities and collection centers across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, and Philadelphia. Our network ensures convenient access to this advanced genetic testing regardless of your location.
Take Control of Your Cancer Treatment Today
Don’t leave your treatment decisions to chance. The Oncopro EGFR Rapid Test provides the critical genetic information needed to pursue the most effective targeted therapy for your specific type of lung cancer. With rapid results and comprehensive analysis, this test represents a crucial step toward personalized cancer care.
Ready to get started? Book your Oncopro EGFR Rapid Test today by calling our dedicated patient care line at +1(267) 388-9828 or schedule your appointment online. Our genetic counselors and oncology specialists are available to answer your questions and guide you through the testing process.
Take the first step toward personalized cancer treatment – contact us now to schedule your Oncopro EGFR Rapid Test and gain the genetic insights needed for optimal therapeutic decisions.
